-
Neurointerventional consumables spring ring collection: sweeping 21 provinces Resurrection mechanism
Time of Update: 2022-10-31
The selection rules of the 21 provincial spring ring collective procurement alliance are relatively modest A resurrection mechanism exists in both groups of AB From the perspective of the centralized procurement rules of the 21 provinces, the proposed selection rules are quite moderate, and the products are divided into two groups of AB according to the size of the medical institutions.
-
The legendary creature CAR-T sells well in Europe and the United States! Domestic CAR-T is still involutional! "Going to sea" through the winter?
Time of Update: 2022-10-31
October 2017 Targeting CD19 The FDA approved Gilead's Yescarta for the treatment of adult patients with relapsed or refractory large B-cell lymphoma (LBCL) who have previously received second- or multi-line systemic therapy.
-
Epimedium/glycoside 10% 20% 40% 98% Epimedium extract industry dynamics
Time of Update: 2022-10-31
[Use part]: Leaf [Distribution area]: Most of the country, Gansu, Sichuan, Shaanxi [Product specifications]: Icariin / glycoside 10% 20% 40% 60% 98% [detection method] 【Product appearance】:Brown yellow to bright yellow powder 【Physical properties】:soluble in alcohol, slightly soluble in water 【Storage method】:Sealed in a cool, dry place [Packing]: Aluminum foil bag 1kg/bag, 25kg/barrel or according to customer requirements 【Shelf life】: 24 months 【Shipping place】:Xi'an 【Manufacturer】:Quercus alcaena [Species]:Plant extract-Epimedium extract 2.
-
Quercus Pinnacle Bio supplies 1% 98% white potato extract industry dynamics
Time of Update: 2022-10-31
【Part of use】:Root of Ulgaris [Ingredients]: Euranthrin, isolutein, Baizhi polysaccharide 【Plant Distribution】:Nationwide 【Product Specifications】:Luteanocarbin 1% 50% 98% 【Detection Method】:HPLC 【 Product appearance]: brown yellow to off-white [product status]: fine powder [storage method]: sealed in a cool, dry place [packing]: aluminum foil bag 1kg/bag, 25kg/barrel or according to customer requirements [shelf life]: 24 months Quercus Ping Bio supplies Lutein 1% 98% White Pycnogenol Extract Industry News 1.
-
The Food and Drug Administration announced the full implementation of electronic registration certificates for medical devices
Time of Update: 2022-10-31
In order to implement the important decisions and deployments of the Party Central Committee and the State Council on deepening the reform of "decentralization, management and service", optimize the
-
76 listed companies have been investigated by institutions, and the head of medical devices has been "stepped on the threshold"
Time of Update: 2022-10-31
com) This week (October 24-October 28), the pharmaceutical and biological industry is still favored by institutions, and the institutions have investigated a large number of companies including Yuyue Medical, Salubris, Puli Pharmaceutical, Chutian Technology, Kaikai Medical, RheinBiologics, Dirui Medical, etc.
-
The latest: 8 provinces and cities have clarified the implementation time of the seventh batch of national collective procurement
Time of Update: 2022-10-31
pharmacies The agreed procurement volume and procurement cycle of the seventh batch of selected products in the first year shall be determined in accordance with the relevant rules in the National Centralized Drug Procurement Document (GY-YD2022-1) issued by the National Joint Procurement Office.
-
Citrus aurantium extract hesperidin/glycoside 90% 92% 98% synephrine 6% industry dynamic analysis
Time of Update: 2022-10-31
and its cultivar or dried young fruit of sweet orange Citrus sinensis Osbeck 【Part of use】:Young fruit 【Distribution Area】:South China 【Product specifications】:Hesperidin / glycoside 90% 92% 98% [Detection method]: HPLC [Product appearance]: brown yellow powder [Physical properties]: 1 gram dissolved in 50 liters of water [Storage method]: sealed in a cool, dry place [Packing]: aluminum foil bag 1kg/bag, 25kg/barrel or according to customer requirements 【Shelf life】: 24 months 【Shipping place】:Xi'an 【Manufacturer】:Quercus alcaena [Species]:Plant extract-Citrus aurantium extract 2.
-
The pharmaceutical company's core technical staff left to be responsible for the company's clinical research in the United States full-time as a consultant
Time of Update: 2022-10-31
EDWARD JOW FANG JOINED MENGKE PHARMACEUTICAL IN 2017, AND BEFORE LEAVING HIS JOB, HE SERVED AS SENIOR VICE PRESIDENT OF MENGKE USA, AND WAS THE COMPANY'S CORE TECHNICAL PERSONNEL, MAINLY RESPONSIBLE FOR CARRYING OUT CLINICAL RESEARCH IN THE UNITED STATES.
-
Pharmaceutical companies are strengthening the domestic substitution of upstream equipment, and pharmaceutical machinery companies will welcome the benefits
Time of Update: 2022-10-31
In recent years, with the growth of R&D investment by domestic biopharmaceutical enterprises and the promotion of a series of policies to encourage and encourage new drug research and development, the domestic biopharmaceutical industry is booming.
-
In order to break the monopoly of multinational pharmaceutical companies in the GLP-1 field, domestic pharmaceutical companies are making efforts
Time of Update: 2022-10-31
In July, Huadong Pharmaceutical announced that its marketing authorization application for liraglutide injection for obesity or overweight indications has been accepted by the State Food and Drug Administration.
-
Reply to the proposal on further strengthening the construction of the traceability system for traditional Chinese medicines
Time of Update: 2022-10-31
Member Wang Rui: After receiving the "Proposal on Further Strengthening the Construction of the Traceability System for Traditional Chinese Medicine" put forward, our bureau, together with the Minist
-
Yuandong Biotechnology's R&D investment rose by another 30%, and the collective collection variety led the market
Time of Update: 2022-10-31
Recently, Yuandong Biotech announced the results of the first three quarters of this year, with both revenue and net profit increasing, with revenue reaching 898 million yuan and net profit of 195 mi
-
After 15 years, the management measures for drug GLP certification will be overhauled!
Time of Update: 2022-10-31
Experimental animals used for non-clinical safety evaluation studies of drugs should indicate the specific names of the laboratory animal production licenses issued by the state and provide relevant supporting materials, and the quarantine situation shall include the recent health of the animal population and the results of pathogenic microorganism testing.
-
Henan has 10 national regional medical center projects
Time of Update: 2022-10-31
According to the construction plan, Peking University Sixth Hospital will rely on Henan Provincial Psychiatric Hospital (the second affiliated hospital of Xinxiang Medical College) to establish Henan Hospital, with 1,000 beds and 1,200 staffing.
-
15-valent pneumonia vaccine! EU approval of Vaxneuvance: for people aged 6 weeks - under 18 years old!
Time of Update: 2022-10-31
October 25, 2022 /BioValleyBIOON/ --Merck & Co has announced that the European Commission (EC) has approved Vaxneuvance (15-valent pneumococcal conjugate vaccine [PCV], V114) to expand its indication for active immunization of infants, children and adolescents aged 6 weeks to under 18 years of age to prevent invasive diseases, pneumonia and acute otitis media caused by 15 serotypes of Streptococcus pneumoniae 。 In the EU, Vaxneuvance has previously been approved for use in adults aged 18 and over.
-
In the next five years, the pharmaceutical chain retail industry will usher in rapid development!
Time of Update: 2022-10-31
In recent years, with the normalization of centralized procurement, the separation of medicines, graded diagnosis and treatment, and the continuous improvement of relevant policies in the field of In
-
Institutional research 3 pharmaceutical and biological companies have been surveyed by more than 100 institutions
Time of Update: 2022-10-31
【Pharmaceutical Network Industry News】In the past 5 days (October 18 to October 24), the institutional research stock shows that a total of 51 companies have been investigated by institutions, of which 8 are pharmaceutical and biological companies, namely Junshi Biologics, Walt Dyne, Propharmaceutical, Kai Medical, Poinsettia, Weili Medical, OPCOM Vision, and Zhenghai Biotechnology.
-
PD-L1 pioneer Zhan Lieping Startup, raised $65 million to treat cold tumors through immune normalization
Time of Update: 2022-10-31
Normunity is based on a drug discovery platform developed in Chan Lieping's lab, which allows it to tease out the complex interactions between tumors and the immune system to find new targets that no one else has discovered, and that help tumors form a protective barrier.
-
The API industry has ushered in a period of opportunity, and pharmaceutical companies have accelerated their layout
Time of Update: 2022-10-31
On October 27, Zhongsheng Pharmaceutical issued an announcement that the API brofenac sodium of Xianqiang Pharmaceutical, a wholly-owned subsidiary, was approved for marketing by the State Food and Drug Administration.
